List of Figures
Figure 1: Atopic Dermatitis Therapeutics, South Korea, Age-Specific Prevalence (%), 2012 12
Figure 2: Prevalence of Atopic Dermatitis Associated Symptoms 13
Figure 3: Treatment Algorithm for Atopic Dermatitis Based on Severity 20
Figure 4: Atopic Dermatitis Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products for the Treatment of Atopic Dermatitis 32
Figure 5: Atopic Dermatitis Therapeutics Market, Global, Overview of Pipeline Products, 2018 35
Figure 6: Atopic Dermatitis Therapeutics Market, Global, Pipeline by Molecular Target, 2018 37
Figure 7: Atopic Dermatitis Therapeutics Market, Southeast Asia, Tralokinumab, Market Forecast ($m), 2021–2024 39
Figure 8: Atopic Dermatitis Therapeutics Market, Southeast Asia, Furestem-AD, Market Forecast ($m), 2021–2024 40
Figure 9: Atopic Dermatitis Therapeutics Market, Southeast Asia, Baricitinib, Market Forecast ($m), 2020–2024 42
Figure 10: Atopic Dermatitis Therapeutics Market, Comparative Efficacy and Safety Heatmap for Pipeline Products 45
Figure 11: Atopic Dermatitis Therapeutics Market, Competitor Matrix for AD Marketed and Pipeline Products 46
Figure 12: Atopic Dermatitis Therapeutics Market, Global, Average Clinical Trial Failure Rate (%), 2007–2018 48
Figure 13: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Failure Rates by Molecule Type (%), 2007–2018 49
Figure 14: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Failure Rates by Molecular Target (%), 2007–2018 50
Figure 15: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Size per Trial by Molecule Type (participants), 2007–2018 51
Figure 16: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Size per Trial by Molecular Target (participants), 2007–2018 52
Figure 17: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Size per Product by Molecule Type (participants), 2007–2018 53
Figure 18: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Size per Product by Molecular Target (participants), 2007–2018 54
Figure 19: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecule Type (months), 2007–2018 55
Figure 20: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecular Target (months), 2007–2018 56
Figure 21: Atopic Dermatitis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 56
Figure 22: Atopic Dermatitis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 57
Figure 23: Atopic Dermatitis Therapeutics Market, Southeast Asia, Treatment Usage Pattern (million), 2017–2024 59
Figure 24: Atopic Dermatitis Therapeutics Market, Southeast Asia, Market Size ($m), 2017–2024 60
Figure 25: Atopic Dermatitis Therapeutics Market, South Korea, Treatment Usage Patterns (million), 2017–2024 62
Figure 26: Atopic Dermatitis Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2017–2024 63
Figure 27: Atopic Dermatitis Therapeutics Market, South Korea, Market Size ($m), 2017–2024 64
Figure 28: Atopic Dermatitis Therapeutics Market, Singapore, Treatment Usage Patterns (million), 2017–2024 65
Figure 29: Atopic Dermatitis Therapeutics Market, Singapore, Annual Cost of Therapy ($), 2017–2024 66
Figure 30: Atopic Dermatitis Therapeutics Market, Singapore, Market Size ($m), 2017–2024 67
Figure 31: Atopic Dermatitis Therapeutics Market, Taiwan, Treatment Usage Patterns (million), 2017–2024 68
Figure 32: Atopic Dermatitis Therapeutics Market, Taiwan, Annual Cost of Therapy ($), 2017–2024 69
Figure 33: Atopic Dermatitis Therapeutics Market, Taiwan, Market Size ($m), 2017–2024 70
Figure 34: Atopic Dermatitis Therapeutics Market, Malaysia, Treatment Usage Patterns (million), 2017–2024 71
Figure 35: Atopic Dermatitis Therapeutics Market, Malaysia, Annual Cost of Therapy ($), 2017–2024 72
Figure 36: Atopic Dermatitis Therapeutics Market, Malaysia, Market Size ($m), 2017–2024 72
Figure 37: Atopic Dermatitis Therapeutics Market, Philippines, Treatment Usage Patterns (million), 2017–2024 73
Figure 38: Atopic Dermatitis Therapeutics Market, Philippines, Annual Cost of Therapy ($), 2017–2024 74
Figure 39: Atopic Dermatitis Therapeutics Market, Philippines, Market Size ($m), 2017–2024 75
Figure 40: Atopic Dermatitis Therapeutics Market, Thailand, Treatment Usage Patterns (million), 2017–2024 76
Figure 41: Atopic Dermatitis Therapeutics Market, Thailand, Annual Cost of Therapy ($), 2017–2024 77
Figure 42: Atopic Dermatitis Therapeutics Market, Thailand, Market Size ($m), 2017–2024 78
Figure 43: Atopic Dermatitis Therapeutics Market, Vietnam, Treatment Usage Patterns (million), 2017–2024 79
Figure 44: Atopic Dermatitis Therapeutics Market, Vietnam, Annual Cost of Therapy ($), 2017–2024 79
Figure 45: Atopic Dermatitis Therapeutics Market, Vietnam, Market Size ($m), 2017–2024 80
Figure 46: Atopic Dermatitis Therapeutics Market, Indonesia, Treatment Usage Patterns (million), 2017–2024 81
Figure 47: Atopic Dermatitis Therapeutics Market, Indonesia, Annual Cost of Therapy ($), 2017–2024 82
Figure 48: Atopic Dermatitis Therapeutics Market, Indonesia, Market Size ($m), 2017–2024 83
Figure 49:Atopic Dermatitis Therapeutics Market, Global, Licensing Deals by Region and Value, 2007–2018 86
Figure 50: Atopic Dermatitis Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2007–2018 87
Figure 51: Atopic Dermatitis Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2007–2018 88
Figure 52: Atopic Dermatitis Therapeutics, Global, Licensing Deals by Molecule Type and Stage of Development, 2007–2018 89
Figure 53: Atopic Dermatitis Therapeutics, Global, Licensing Deals by Molecular Targets and Aggregate Deal Value ($), 2007–2018 90
Figure 54:Atopic Dermatitis Therapeutics Market, Global, Co-development Deals by Region, 2007–2018 92